Characteristics of multidrug-resistant Acinetobacter baumannii strains isolated in Geneva during colonization or infection

Annals of Clinical Microbiology and Antimicrobials

Volumn 14, Issue 1, 2015, Pages

  Cherkaoui, Abdessalam ^a   Emonet, Stéphane ^a   Renzi, Gesuele ^a   Schrenzel, Jacques ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Acinetobacter baumannii; DiversiLab; Multi drug resistant; PCR; rep PCR; lactamase genes

Indexed keywords

AMIKACIN; BETA LACTAM; CARBAPENEMASE; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLAGES 11 GENE; BLAGES GENE; BLAIMP GENE; BLAKPC GENE; BLANDM GENE; BLAOXA 23 GENE; BLAOXA 24 GENE; BLAOXA 51 GENE; BLAOXA 58 GENE; BLASPM GENE; BLAVIM GENE; CHILD; DISK DIFFUSION; EPSILOMETER TEST; FEMALE; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; MALE; MIC50; MIC90; MIDDLE AGED; MULTIDRUG RESISTANCE; NDM 1 GENE; NONHUMAN; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SWITZERLAND; YOUNG ADULT; ACINETOBACTER INFECTIONS; CLASSIFICATION; DRUG EFFECTS; GENETIC VARIATION; GENETICS; GENOTYPE; HETEROZYGOTE; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR TYPING; VERY ELDERLY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARRIER STATE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENETIC VARIATION; GENOTYPE; HOSPITALS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; POLYMERASE CHAIN REACTION; SWITZERLAND; YOUNG ADULT;

EID: 84941286558     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/s12941-015-0103-3     Document Type: Article

References (36)

1. Yamamoto M, Nagao M, Matsumura Y, Matsushima A, Ito Y, Takakura S, Ichiyama S. Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among Acinetobacter species in Japan. J Antimicrob Chemother. 2011;66(11):2480-3.
2. Villalon P, Valdezate S, Medina-Pascual MJ, Carrasco G, Vindel A, Saez-Nieto JA. Epidemiology of the Acinetobacter-derived cephalosporinase, carbapenem-hydrolysing oxacillinase and metallo-beta-lactamase genes, and of common insertion sequences, in epidemic clones of Acinetobacter baumannii from Spain. J Antimicrob Chemother. 2013;68(3):550-3.
3. Agodi A, Voulgari E, Barchitta M, Quattrocchi A, Bellocchi P, Poulou A, Santangelo C, Castiglione G, Giaquinta L, Romeo MA, Vrioni G, Tsakris A. Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals. J Hosp Infect. 2014;86(4):260-6.
4. Heritier C, Poirel L, Lambert T, Nordmann P. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother. 2005;49(8):3198-202.
5. Quale J, Bratu S, Landman D, Heddurshetti R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis Off Publ Infect Dis Soc Am. 2003;37(2):214-20.
6. Amudhan MS, Sekar U, Kamalanathan A, Balaraman S. bla(IMP) and bla(VIM) mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India. J Infect Develop Ctries. 2012;6(11):757-62.
7. Thomson JM, Bonomo RA. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril! Curr Opin Microbiol. 2005;8(5):518-24.
8. Cicek AC, Saral A, Iraz M, Ceylan A, Duzgun AO, Peleg AY, Sandalli C. OXA- and GES-type beta-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect. 2014;20(5):410-5.
9. Tsakris A, Ikonomidis A, Pournaras S, Tzouvelekis LS, Sofianou D, Legakis NJ, Maniatis AN. VIM-1 metallo-beta-lactamase in Acinetobacter baumannii. Emerg Infect Dis. 2006;12(6):981-3.
10. Kusradze I, Diene SM, Goderdzishvili M, Rolain JM. Molecular detection of OXA carbapenemase genes in multidrug-resistant Acinetobacter baumannii isolates from Iraq and Georgia. Int J Antimicrob Agents. 2011;38(2):164-8.
11. Lee YT, Kuo SC, Chiang MC, Yang SP, Chen CP, Chen TL, Fung CP. Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii. Antimicrob Agents Chemother. 2012;56(2):1124-7.
12. Ghazawi A, Sonnevend A, Bonnin RA, Poirel L, Nordmann P, Hashmey R, Rizvi TA, Bh M, Pal T. NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2012;18(2):E34-6.
13. Poirel L, Bonnin RA, Boulanger A, Schrenzel J, Kaase M, Nordmann P. Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii. Antimicrob Agents Chemother. 2012;56(2):1087-9.
14. Abbas M, Cherkaoui A, Fankhauser C, Schrenzel J, Harbarth S. Epidemiology and clinical implications of carbapenemase-producing bacteria in Switzerland. Revue Medicale Suisse. 2012;8(338):882-4.
15. Chen Y, Zhou Z, Jiang Y, Yu Y. Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother. 2011;66(6):1255-9.
16. Pfeifer Y, Wilharm G, Zander E, Wichelhaus TA, Gottig S, Hunfeld KP, Seifert H, Witte W, Higgins PG. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother. 2011;66(9):1998-2001.
17. Kaase M, Nordmann P, Wichelhaus TA, Gatermann SG, Bonnin RA, Poirel L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother. 2011;66(6):1260-2.
18. Espinal P, Fugazza G, Lopez Y, Kasma M, Lerman Y, Malhotra-Kumar S, Goossens H, Carmeli Y, Vila J. Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemother. 2011;55(11):5396-8.
19. Doi Y, Onuoha EO, Adams-Haduch JM, Pakstis DL, McGaha TL, Werner CA, Parker BN, Brooks MM, Shutt KA, Pasculle AW, Muto CA, Harrison LH. Screening for Acinetobacter baumannii colonization by use of sponges. J Clin Microbiol. 2011;49(1):154-8.
20. Corbella X, Pujol M, Ayats J, Sendra M, Ardanuy C, Dominguez MA, Linares J, Ariza J, Gudiol F. Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis Off Publ Infect Dis Soc Am. 1996;23(2):329-34.
21. Adler A, Navon-Venezia S, Moran-Gilad J, Marcos E, Schwartz D, Carmeli Y. Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs. J Clin Microbiol. 2011;49(6):2239-42.
22. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Infect Dis Off Publ Infect Dis Soc Am. 2012;18(3):268-81.
23. Cherkaoui A, Hibbs J, Emonet S, Tangomo M, Girard M, Francois P, Schrenzel J. Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species level. J Clin Microbiol. 2010;48(4):1169-75.
24. Adams-Haduch JM, Paterson DL, Sidjabat HE, Pasculle AW, Potoski BA, Muto CA, Harrison LH, Doi Y. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob Agents Chemother. 2008;52(11):3837-43.
25. Nowak P, Paluchowska P, Budak A. Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosocomial strains in Poland. New Microbiol. 2012;35(3):317-25.
26. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538-82.
27. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006;44(8):2974-6.
28. Decousser JW, Jansen C, Nordmann P, Emirian A, Bonnin RA, Anais L, Merle JC, Poirel L. Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013. Eurosurveillance. 2013;18(31). doi: 10.2807/1560-7917.ES2013.18.31.20547
29. Yang J, Chen Y, Jia X, Luo Y, Song Q, Zhao W, Wang Y, Liu H, Zheng D, Xia Y, Yu R, Han X, Jiang G, Zhou Y, Zhou W, Hu X, Liang L, Han L. Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2012;18(12):E506-13.
30. Toleman MA, Spencer J, Jones L, Walsh TR. blaNDM-1 is a chimera likely constructed in Acinetobacter baumannii. Antimicrob Agents Chemother. 2012;56(5):2773-6.
31. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, Amyes SG, Livermore DM. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27(4):351-3.
32. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119-23.
33. Cicek AC, Saral A, Iraz M, Ceylan A, Duzgun AO, Peleg AY, Sandalli C. OXA- and GES-type beta-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2014;20(5):410-5.
34. Swayne RL, Ludlam HA, Shet VG, Woodford N, Curran MD. Real-time TaqMan PCR for rapid detection of genes encoding five types of non-metallo- (class A and D) carbapenemases in Enterobacteriaceae. Int J Antimicrob Agents. 2011;38(1):35-8.
35. Naas T, Ergani A, Carrer A, Nordmann P. Real-time PCR for detection of NDM-1 carbapenemase genes from spiked stool samples. Antimicrob Agents Chemother. 2011;55(9):4038-43.
36. Hindiyeh M, Smollen G, Grossman Z, Ram D, Davidson Y, Mileguir F, Vax M, Ben David D, Tal I, Rahav G, Shamiss A, Mendelson E, Keller N. Rapid detection of blaKPC carbapenemase genes by real-time PCR. J Clin Microbiol. 2008;46(9):2879-83.